Elise van Mulligen (@elisevmulligen) 's Twitter Profile
Elise van Mulligen

@elisevmulligen

Postdoc @LUMC_leiden & @ErasmusMC |
Rheumatology | Epidemiologist

ID: 996289244409802752

calendar_today15-05-2018 07:20:40

175 Tweet

188 Takipçi

354 Takip Edilen

The BMJ (@bmj_latest) 's Twitter Profile Photo

#Barbie should expand her range of medical and scientific professions, concludes #ChristmasBMJ study. Barbie brand medical professional dolls largely treated children and no scientist Barbie brand dolls met proper PPE requirements for hair & clothes 😷 bmj.com/content/383/bm…

The Lancet Rheumatology (@thelancetrheum) 's Twitter Profile Photo

NEW in The Lancet—The ARIAA and APIPPRA trials show that T-cell co-stimulation modulation with #abatacept in individuals at high risk of #rheumatoidarthritis reduces progression to rheumatoid arthritis with no new safety signals

NEW in <a href="/TheLancet/">The Lancet</a>—The ARIAA and APIPPRA trials show that T-cell co-stimulation modulation with #abatacept in individuals at high risk of #rheumatoidarthritis reduces progression to rheumatoid arthritis with no new safety signals
Elise van Mulligen (@elisevmulligen) 's Twitter Profile Photo

Interested in doing a #PhD ? Do you have affinity with #epidemiology, imaging (#MRI), or investigating prevention of #RA ? Join our team at Erasmus MC to work on the Clinically Suspect Arthralgia cohort! werkenbijerasmusmc.nl/vacature/96322… EMEUNET @DrReumatologo Sytske Anne

Elise van Mulligen (@elisevmulligen) 's Twitter Profile Photo

Heb je affiniteit met #epidemiologisch onderzoek, #imaging of met preventie van #RA? En zoek je een uitdagende onderzoekspositie? Kom werken in ons team als #PhD student aan het Clinically Suspect Arthralgia Cohort Erasmus MC meer info: werkenbijerasmusmc.nl/vacature/96322… of stuur een DM

The Lancet Rheumatology (@thelancetrheum) 's Twitter Profile Photo

NEW RESEARCH—3-year results from the ARCTIC REWIND trial show that two conventional synthetic DMARD tapering strategies were associated with significantly lower rates of flare-free survival compared with stable conventional synthetic DMARD treatment thelancet.com/journals/lanrh…

NEW RESEARCH—3-year results from the ARCTIC REWIND trial show that two conventional synthetic DMARD tapering strategies were associated with significantly lower rates of flare-free survival compared with stable conventional synthetic DMARD treatment
thelancet.com/journals/lanrh…
EMEUNET (@emeunet) 's Twitter Profile Photo

📢The EMEUNET & PARE Joint Event at the EULAR 2024 Congress! ➡Do not miss this unique opportunity to collaborate with PARE! ⭐ Join interactive platform to learn, engage, network! 🗓️Friday, 14 June 🔔 Registration Deadline: 17 May For registration ➡pulse.ly/9pd8ttcsiv

EMEUNET (@emeunet) 's Twitter Profile Photo

🔥Don't miss out the #EMEUNET meets #PARE event at #EULAR2024!🔥 ⭐️ small group meetings with patient experts ⭐️ innovative approach to patient involvement ⭐️ ensure that your research makes a true impact ⏳️ Deadline: Monday 20th! Apply now: pulse.ly/9cmawmlnv6

Sytske Anne (@sytskeanne) 's Twitter Profile Photo

I am invited to talk about individual patient data meta-analysis in a very interesting EMEUNET presents session at #EULAR2024. You can visit my presentation at Thursday in room A8.1, from 13:30 to 14:45.

I am invited to talk about individual patient data meta-analysis in a very interesting <a href="/EMEUNET/">EMEUNET</a> presents session at #EULAR2024.

You can visit my presentation at Thursday in room A8.1, from 13:30 to 14:45.
Elise van Mulligen (@elisevmulligen) 's Twitter Profile Photo

Should we treat patients with #CSA or not? Today I will present our results on #costeffectiveness of treatment with MTX in CSA patients (#TREATEARLIER trial) to shed light on this debate. Join the first poster tour of #EULAR2024 at 15.30 in hall C!

Should we treat patients with #CSA or not? Today I will present our results on #costeffectiveness of treatment with MTX in CSA patients (#TREATEARLIER trial) to shed light on this debate. Join the first poster tour of #EULAR2024 at 15.30 in hall C!
Dr. John Cush (@rheumnow) 's Twitter Profile Photo

Earlier RA Diagnosis Leads to Lower Costs of Care A study from the Leiden Early Arthritis Clinic shows that is RA is diagnosed within 12 weeks after symptom onset, treatment costs were lower in both autoantibody-negative and autoantibody-positive RA. buff.ly/3LzxuT4

Earlier RA Diagnosis Leads to Lower Costs of Care 

A study from the Leiden Early Arthritis Clinic shows that is RA is diagnosed within 12 weeks after symptom onset, treatment costs were lower in both autoantibody-negative and autoantibody-positive RA. 

buff.ly/3LzxuT4
EMEUNET (@emeunet) 's Twitter Profile Photo

📣 Calling all rheumatology trainees and early career rheumatologists! 📣 🌍 Want to attend Europe’s flagship rheumatology event but facing challenges? 🌍 EMEUNET is here to listen! 🧑‍⚕️ 📋 Click here to take the survey: tr.surveymonkey.com/r/barriers_att… #EMEUNET #EULAR

📣 Calling all rheumatology trainees and early career rheumatologists! 📣

🌍 Want to attend Europe’s flagship rheumatology event but facing challenges? 🌍

EMEUNET is here to listen! 🧑‍⚕️

📋 Click here to take the survey: tr.surveymonkey.com/r/barriers_att…

#EMEUNET #EULAR
The Lancet Rheumatology (@thelancetrheum) 's Twitter Profile Photo

NEW RESEARCH—DMARD-free #remission is attainable in patients with #rheumatoidarthritis who do not require biological DMARDs, whereas those who require biological DMARDs have a negligible chance of reaching sustained DMARD-free remission thelancet.com/journals/lanrh…

NEW RESEARCH—DMARD-free #remission is attainable in patients with #rheumatoidarthritis who do not require biological DMARDs, whereas those who require biological DMARDs have a negligible chance of reaching sustained DMARD-free remission thelancet.com/journals/lanrh…
EMEUNET (@emeunet) 's Twitter Profile Photo

🌍 EMEUNET & Young PANLAR joint webinar! 🔹 Achieving Remission in RA & PsA – Innovations & Insights 📅 April 8 | 18h CEST 🎙Dr. van Mulligen (RA) & Dr. Ribeiro (PsA) -Moderators: Dr. Gómez & Dr. Bautista -Presenter: Dr. Aouad   🔗 Register here: us02web.zoom.us/meeting/regist…

🌍 EMEUNET &amp; Young PANLAR joint webinar! 
🔹 Achieving Remission in RA &amp; PsA – Innovations &amp; Insights
📅 April 8 | 18h CEST
🎙Dr. van Mulligen (RA) &amp; Dr. Ribeiro (PsA)
-Moderators: Dr. Gómez &amp; Dr. Bautista
-Presenter: Dr. Aouad
 
🔗 Register here: us02web.zoom.us/meeting/regist…
Elise van Mulligen (@elisevmulligen) 's Twitter Profile Photo

One step closer to #precision #prevention of #rheumatoid arthritis? Let's meet and discuss at this afternoon's poster view at #EULAR2025 See you there!

One step closer to #precision #prevention of #rheumatoid arthritis? 

Let's meet and discuss at this afternoon's poster view at
#EULAR2025 

See you there!
Elise van Mulligen (@elisevmulligen) 's Twitter Profile Photo

🚨 We are hiring a #postdoc in #Rheumatology & #ComputationalBiology at LUMC Leiden! Join our team to analyze multi-omics & clinical data from the pioneering TREAT EARLIER trial, the first preventive RA study. Apply now academictransfer.com/nl/jobs/354900… EMEUNET